200230.KQ
TELCON RF PHARMACEUTICAL. Inc.
KOE · Technology · Communication Equipment · KR
KRW 2,225.00
+0.23%Year over year
Reported trailing growth
- Revenue
- +50.6%
- EBITDA
- +225.0%
- EBIT
- —
- EPS
- +75.6%
- Free cash flow
- +101.2%
- Operating cash flow
- +292.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +15.8%
- EBITDA
- -42.6%
- EBIT
- -57.8%
- Net income
- +56.5%
- EPS
- +92.3%
- Free cash flow
- +135.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026